NCT00337545View on ClinicalTrials.gov

Phase II Trial of RAD001 in Refractory Colorectal Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

April 30, 2007

Conditions

Colorectal Cancer

Interventions

DRUG

RAD001

Trial Locations (1)

98104

Swedish Cancer Institute, Seattle

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

Swedish Medical Center

OTHER